CD274 and neoplasm: One explanation for the concurrent reduction in cytotoxic killing and expression of PD-1 on tumor CD8+T cells could be that beyond the PD-1/PD-L1 axis other checkpoint inhibitors may inhibit CD8+ T cell cytotoxicity (44) in Stage I endometrial tumors.